This webinar discussed the July 2024 peer-reviewed publication “Acute effects of cannabigerol on anxiety, stress, and mood: a double blind, placebo controlled, crossover, field trial”, by Carrie Cuttler, Amanda Stueber, Ziva D. Cooper & Ethan Russo.
Dr. Russo, preeminent pharmacologist, neurologist and medical cannabis researcher, presented the findings of this important work. It is the first randomized placebo controlled clinical trail to investigate the effects of cannabigerol (CBG) on anxiety, mood, and stress and is a major step forward in demonstrating safety and efficacy of the molecule.
This webinar:
1) Reviewed the history and basic science of CBG.
2) Reviewed the recent Scientific Reports article by Cuttler et al. demonstrating anti-anxiety and anti-stress responses of CBG without impairment in a randomized controlled trial
3) Provided a greater understanding of the therapeutic benefits of CBG
The webinar is now available for purchase and download at: https://buycredo.mm411.com/
